(PharmaNewsWire.Com, December 18, 2017 ) Medical ablation is the treatment that destroys tumors or unwanted material without affecting other body tissues or organs. Because of poor health or reduced organ function, these techniques are widely used to treat cancer, cardiovascular and other chronic diseases. In the treatment of chronic diseases, medical ablation plays the prime role in the removal or complete destruction of abnormal tissue.
The market for Ablation Technologies is mainly driven due to on-going technological advancements in ablation products, increasing prevalence of cancer and cardiovascular diseases, increasing number of ablation procedures, increasing number of hospitals, surgical, and ablation centers. But, the market growth can be hampered due to reuse and reprocessing of the ablation devices and healthcare cost containment measures.
North America market for Ablation Technologies is segmented based on Product, Type and Application. By Product, the market is further sub-segmented into Light/Laser ablators, Radiofrequency (RF) ablators, Electrical ablators, Ultrasound ablators, Microwave ablators, Cryoablation devices, and Hydrothermal ablators. By Type, the market is further sub-segmented into Light/Laser ablation, Radiofrequency (RF) ablation, Electrical ablation, Ultrasound ablation, Microwave ablation, Cryoablation, and Hydrothermal ablation.
By Application, the market is further sub-segmented into Cardiovascular Disease, Cancer, Ophthalmologic, Gynecologic, Pain Management, Urologic, Orthopedic, Cosmetic Surgery and Other treatments. Radiofrequency-based ablation technology segment is expected to lead the North America ablation technologies market based on Type. Based on Application, large market share is attributed to cardiovascular diseases treatment segment.
Geographically, North America market for Ablation Technologies is segmented into U.S. and Canada. North America is the biggest market in terms of market share across the globe. U.S. holds the major share of contribution due to a larger consumer base, availability of healthcare services, and higher adoption rate of these technologies. Canada’s contribution will also rise due to the adoption of new ablation technologies such as microwave and radiation.
Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., BSD Medical Corporation, are the major players of North America Ablation Technologies market.
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
